Table 2.
Baseline characteristics, top 10 ICPC groups
| Control arm | Experimental arm | GP Experimental arm | NP Experimental arm | |
|---|---|---|---|---|
| Complaints (%)a | ||||
| Skin | 21.7 | 22.7 | 20.7 | 31.2 |
| Musculoskeletal | 20.5 | 20.1 | 19.6 | 22.2 |
| Respiratory | 15.2 | 14.2 | 13.7 | 16.3 |
| Digestive | 10.5 | 9.9 | 11.4 | 3.0 |
| Eye | 6.0 | 6.1 | 6.5 | 4.4 |
| General and unspecified | 5.9 | 6.5 | 6.6 | 6.0 |
| Ear | 5.7 | 5.8 | 5.6 | 6.8 |
| Urological | 5.5 | 5.7 | 5.7 | 5.6 |
| Cardiovascular | 2.5 | 2.5 | 2.9 | 0.7 |
| Neurological | 2.3 | 2.3 | 2.8 | 0.3 |
| Other | 4.2 | 4.2 | 4.5 | 3.5 |
Tested using a Chi2 test
asignificant difference between the GP and NP in the experimental arm